| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.21 | 4e-05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.21 | 5e-05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.2 | 8e-05 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |